Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home

ONIRIA THERAPEUTICS, S.L.

SME

www.oniriatherapeutics.comBarcelona, Spain
4 profile visits

About

Oniria Therapeutics is a biopharmaceutical company focused on precision oncology and addressing cancer persistence and recurrence. Its lead candidate, ONR-688, is entering regulatory preclinical development and has shown in vivo efficacy in colorectal cancer, melanoma, and acute myeloid leukemia, as well as in vitro activity in additional indications such as ovarian, bladder, pancreas, lung and glioblastoma. Acute and sub-chronic safety have been demonstrated in rodents, and acute safety has been confirmed in non-rodents.

Social media

What is your business/industry sector?

Biotech, Pharma and CosmeticsHealthcare

Representatives

ESTHER RIAMBAU

CEO

ONIRIA THERAPEUTICS, S.L.